Prognostic and therapeutic implications of early treatment response assessment in acute myeloid leukemia
- 1 July 2015
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 95 (1) , 38-45
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study groupHaematologica, 2013
- Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemiaCancer, 2012
- The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; The results of multicenter, prospective Polish adult leukemia group studyAmerican Journal of Hematology, 2011
- Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemiaHaematologica, 2010
- Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS studyLeukemia, 2008
- Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemiaHaematologica, 2008
- Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemiaAmerican Journal of Hematology, 2008
- Peripheral blood blast clearance during induction therapy in acute myeloid leukemiaBlood, 2008
- Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survivalBlood, 2007
- Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 TrialBlood, 2003